Einar Stensvold
Overview
Explore the profile of Einar Stensvold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanem K, Stensvold E, Wilberg P, Skaare A, Brandal P, Herlofson B
Support Care Cancer
. 2022 Oct;
30(12):10233-10241.
PMID: 36307656
Purpose: To investigate oral and dental late effects in survivors of childhood brain tumors medulloblastoma (MB) and central nervous system supratentorial primitive neuroectodermal tumor (CNS-PNET). Methods: This cross-sectional study assessed...
2.
Kvammen J, Stensvold E, Godang K, Bollerslev J, Myklebust T, Brandal P, et al.
Clin Nutr ESPEN
. 2022 Jul;
50:162-169.
PMID: 35871919
Background And Aims: Childhood cancer survivors are at risk of unwanted late effects. The primary aim of this study was to assess bone mineral density Z-scores (BMDz) in long-term survivors...
3.
Niehusmann P, Stensvold E, Leske H, Pietsch T, Goschzik T, Gielen G, et al.
Pediatr Blood Cancer
. 2022 May;
69(9):e29736.
PMID: 35570402
Background: An unexplained regional difference in survival was observed in previous publications on outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) in Norway. We aimed now...
4.
Tanem K, Stensvold E, Wilberg P, Skaare A, Singh P, Brandal P, et al.
Support Care Cancer
. 2022 Apr;
30(7):6155-6162.
PMID: 35426047
Purpose: To investigate taste and smell function in survivors, with a minimum of 2 years since treatment of childhood medulloblastoma (MB)/central nervous system supratentorial primitive neuroectodermal tumor (CNS-PNET). Methods: This...
5.
Lundar T, Due-Tonnessen B, Fric R, Brandal P, Stensvold E, Due-Tonnessen P
Childs Nerv Syst
. 2020 Aug;
37(2):427-433.
PMID: 32814984
Background: Long-term outcome for children who underwent surgery for brain tumors in the first 3 years of life is not well-known. Methods: We performed a retrospective study on surgical morbidity,...
6.
Stadskleiv K, Stensvold E, Stokka K, Bechensteen A, Brandal P
Clin Neuropsychol
. 2020 Jul;
36(3):600-625.
PMID: 32729777
To investigate the long-term cognitive consequences of malignant pediatric brain tumor and its treatment, and factors explaining variability in cognitive functioning among survivors. A geographical cohort of survivors of pediatric...
7.
Fric R, Due-Tonnessen B, Lundar T, Egge A, Kronen Krossnes B, Due-Tonnessen P, et al.
Sci Rep
. 2020 Jun;
10(1):9371.
PMID: 32523021
The aim of the study was to analyze the long-term outcome (>20 years) after treatment of posterior fossa medulloblastoma (MB) in childhood. We analyzed data from patients treated for posterior...
8.
Stensvold E, Stadskleiv K, Myklebust T, Wesenberg F, Helseth E, Bechensteen A, et al.
Acta Paediatr
. 2020 Jan;
109(9):1875-1886.
PMID: 31977119
Aim: To study incidence, types and degrees of late effects in a geographical cohort of paediatric medulloblastoma and central nervous system primitive neuroectodermal tumour (CNS-PNET) survivors, and identify the need...
9.
Lundar T, Due-Tonnessen B, Fric R, Brandal P, Stensvold E, Due-Tonnessen P
Acta Neurochir (Wien)
. 2019 Jul;
161(9):1793-1798.
PMID: 31309304
Background: Long-term results for adult patients who underwent surgery for paediatric brain tumours in the first year of life have not been reported. Methods: We performed a retrospective study on...
10.
Stensvold E, Myklebust T, Cappelen J, Due-Tonnessen B, Due-Tonnessen P, Kepka A, et al.
Pediatr Blood Cancer
. 2019 Jul;
66(10):e27910.
PMID: 31264356
Background: A previous study based on Norwegian Cancer Registry data suggested regional differences in overall survival (OS) after treatment for medulloblastoma (MB) and supratentorial primitive neuroectodermal tumor (CNS-PNET) in Norway....